The therapeutic effects of daphnetin in collagen-induced arthritis involve its regulation of Th17 cells
Department of Immunology, Medical College of Nanchang University, 461 Nanchang Bayi Road, Nanchang of Jiangxi Province 330006, China. International immunopharmacology
(Impact Factor: 2.47).
04/2012; 13(4):417-23. DOI: 10.1016/j.intimp.2012.04.001
Daphne odora var. marginata (D. marginata), an aiophyllus arbuscular plant, is one of the traditional Chinese medicines used to treat rheumatoid arthritis. This study investigated the therapeutic effects and mechanisms of daphnetin, an active monomer ingredient derived from D. marginata, on collagen-induced arthritis (CIA) in rats.
The effects of daphnetin on joint diseases were assessed by hematoxylin and eosin staining and radiographic and transmission electron microscopy. The protein and mRNA expression levels of T helper (Th)1/Th2/Th17-type cytokines in the spleen were determined by flow cytometry and quantitative real-time PCR.
Our results showed that daphnetin significantly reduced paw swelling and was nontoxic in vivo at the tested doses. Synovial hyperplasia, joint destruction and chondrocyte degeneration in CIA rats were suppressed by daphnetin. Daphnetin treatment also reduced the levels of Th1/Th2/Th17 type cytokines in spleen lymphocytes in CIA rats. Moreover, the expression of Foxp3, which can down-regulate the activity of Th17 cells, was significantly increased in the daphnetin-treated groups.
These results suggest that daphnetin may have therapeutic effects in down-regulating Th17-type responses in CIA rats. The beneficial effects of daphnetin on CIA may be related to its inhibition of Th17 cell priming and activation.
Available from: PubMed Central
- "Daphnetin (7, 8-dihydroxycoumarin), one of coumarin derivatives, is an effective compound extracted from a plant called Daphne Korean Nakai, with a molecular weight of 178 , . It has been clinically used in the treatment of coagulation disorders, rheumatoid arthritis, lumbago and to reduce fever , , . Furthermore, the daphnetin displays a significant anti-cancer effect and inhibits kinase activity in vitro
, . "
[Show abstract] [Hide abstract]
ABSTRACT: Daphnetin, a plant-derived dihydroxylated derivative of coumarin, is an effective compound extracted from a plant called Daphne Korean Nakai. Coumarin derivates were known for their antithrombotic, anti-inflammatory, and antioxidant activities. The present study was aimed to determine the immunosuppressive effects and the underlying mechanisms of daphnetin on concanavalin A (ConA) induced T lymphocytes in mice. We showed that, in vitro, daphnetin suppressed ConA-induced splenocyte proliferation, influenced production of the cytokines and inhibited cell cycle progression through the G0/G1 transition. The data also revealed that daphnetin could down-regulate activation of ConA induced NF-κB and NFAT signal transduction pathways in mouse T lymphocyte. In vivo, daphnetin treatment significantly inhibited the 2, 4- dinitrofluorobenzene (DNFB) -induced delayed type hypersensitivity (DTH) reactions in mice. Collectively, daphnetin had strong immunosuppressive activity both in vitro and in vivo, suggesting a potential role for daphnetin as an immunosuppressive agent, and established the groundwork for further research on daphnetin.
PLoS ONE 05/2014; 9(5):e96502. DOI:10.1371/journal.pone.0096502 · 3.23 Impact Factor
[Show abstract] [Hide abstract]
ABSTRACT: Background: Rheumatoid arthritis (RA) is an autoimmune disease that leads to chronic inflammation in the joints with subsequent cartilage and bone destruction. RA induces a massive burden on health services worldwide. Aim of the work: This study was designed to evaluate the possible therapeutic effect of ‘Chaetomium globosum’ extract in the treatment of RA in a rat model. Materials and methods: Forty male Wistar albino rats aged 8–10 weeks were divided into four groups of 10 rats each. The control group (group I) was injected subcutaneously with 0.1 ml of saline. RA was induced in the other three groups (groups II, III, and IV) by single subcutaneous injection of 0.1 ml of complete Freund’s adjuvant in the footpad of the right hind paw. Group II was induced with arthritis and left untreated. Rats in groups III and IV were treated by administering either C. globosum 10 μg/kg or methotrexate (MTX) 0.3 mg/kg subcutaneously twice weekly for 2 weeks from day 12 after induction of arthritis. Animals of all groups were sacrificed on day 28 from the start of the experiment. The ankle joints were processed and stained with H&E, Masson’s trichrome, and immunohistochemical stain for inducible nitric oxide synthase. Specimens were also processed for transmission electron microscopic study. Results: Untreated arthritic rats revealed paw swelling, synovial hyperplasia, inflammatory infiltration, collagen accumulation, cartilage degradation, bone destruction, and significant increase in inducible nitric oxide synthase-positive chondrocytes. Transmission electron microscopic examination confirmed these results. The present study demonstrated for the first time that C. globosum significantly reduced all the clinical and histopathological changes of arthritis similar to MTX. Conclusion: C. globosum extract had therapeutic effects similar to the well-established drug MTX and could be devoid of its serious side effects.
Egyptian Journal of Histology 12/2013; 36(4):964-978. DOI:10.1097/01.EHX.0000440708.76464.de
[Show abstract] [Hide abstract]
ABSTRACT: Daphnetin (DAP), a coumarin derivative, has been reported to have multiple pharmacological actions including analgesia, antimalarial, anti-arthritic, and anti-pyretic properties. It is unclear whether DAP has neuroprotective effects on ischemic brain injury. In this study, we found that DAP treatment (i.c.v.) reduced the infarct volume at 24 h after ischemia/reperfusion injury and improved neurological behaviors in a middle cerebral artery occlusion mouse model. Moreover, we provided evidences that DAP had protective effects on infarct volume in neonate rats even it was administrated at 4 h after cerebral hypoxia/ischemia injury. To explore its neuroprotective mechanisms of DAP, we examined the protection of DAP on glutamate toxicity-induced cell death in hippocampal HT-22 cells. Our results demonstrated that DAP protected against glutamate toxicity in HT-22 cells in a concentration-dependent manner. Further, we found that DAP maintained the cellular levels of glutathione and superoxide dismutase activity, suggesting the anti-oxidatant activity of DAP. Since DAP has been used for the treatment of coagulation disorder and rheumatoid arthritis for long time with a safety profile, DAP will be a promising agent for the treatment of stroke.
Neurochemical Research 12/2013; 39(2). DOI:10.1007/s11064-013-1218-6 · 2.59 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.